HAEMOCHROMATOSIS UK
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net expenditure of £47,539 for the year, resulting in a deficit against the anticipated £47.5k. Total unrestricted reserves stood at £239,492, which the trustees noted was being reduced from a carried-forward balance of £406k to avoid holding large funds that are detrimental to securing future funding.
What the accounts disclose
“The Charity has a policy on reserve policy establishing a contingency reserve fund sufficient to meet between six to nine months’ unrestricted expenditure.” — page 6
“The Charity examiners opinion has been given on a going concern basis in relation to the 2024 financial year. At the time of finalising this report, the Charity is managing material financial risks connected with ongoing matters relating to its former CEO.” — page 7
“At the time of finalising this report, the Charity is managing material financial risks connected with ongoing matters relating to its former CEO. The Board of Trustees is actively monitoring and assessing the potential impact of these issues on the Charity’s financial position, and appropriate notifications have been made to the Charity Commission.”
Year-over-year changes
- Going concern: no going-concern doubt (FY2023) → going-concern doubt noted (FY2024).
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Aaron Venables
- Dieter Krapp
- Guillaume Fillias
- Pippa Randolph
- Sarah Vousden
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £575k | £623k |
| 31/12/2023 | £424k | £394k |
| 31/12/2022 | £437k | £457k |
| 31/12/2021 | £366k | £326k |
| 31/12/2020 | £318k | £229k |
Common questions
Is HAEMOCHROMATOSIS UK financially healthy?
The accounts state that the charity reported a net expenditure of £47,539 for the year, resulting in a deficit against the anticipated £47.5k. Total unrestricted reserves stood at £239,492, which the trustees noted was being reduced from a carried-forward balance of £406k to avoid holding large funds that are detrimental to securing future funding. Its FY2024 accounts were independently examined.
Who funds HAEMOCHROMATOSIS UK?
Funders whose own accounts filings name HAEMOCHROMATOSIS UK as a grant recipient include THE EVELYN TRUST, ROBERT LUFF FOUNDATION LIMITED, THE SHEARS FOUNDATION, THE STRATTON NO2 CHARITABLE FUND, BOOTS CHARITABLE TRUST.
Known funders
| Funder | Year | Amount |
|---|---|---|
| THE EVELYN TRUST | FY2025 | £60k |
| ROBERT LUFF FOUNDATION LIMITED | FY2025 | £50k |
| THE EVELYN TRUST | FY2024 | £50k |
| THE SHEARS FOUNDATION | FY2025 | £20k |
| THE STRATTON NO2 CHARITABLE FUND | FY2024 | £10k |
| ROBERT LUFF FOUNDATION LIMITED | FY2023 | £10k |
| BOOTS CHARITABLE TRUST | FY2023 | £10k |
| THE BATCHWORTH TRUST | FY2024 | £5k |
| THE THACKRAY MEDICAL RESEARCH TRUST | FY2023 | £4k |
| THE ASTOR FOUNDATION | FY2025 | £2k |
| THE ASTOR FOUNDATION | FY2022 | £1k |
| CHAPMAN CHARITABLE TRUST | FY2022 | £1k |
| ANSON CHARITABLE TRUST | FY2022 | £500 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SIR SAMUEL SCOTT OF YEWS TRUST | 3 | £36k |
| PILKINGTON CHARITIES FUND | 2 | £14k |
| THE INMAN CHARITY | 2 | £14k |
| THE SIR JAMES ROLL CHARITABLE TRUST | 2 | £12k |
| THE IAN FLEMING CHARITABLE TRUST | 2 | £5k |
| THE FRANCES AND AUGUSTUS NEWMAN FOUNDATION | 1 | £176k |
| PROJECT GIVING BACK | 1 | £84k |
| DAVID & RUTH LEWIS FAMILY CHARITABLE TRUST | 1 | £55k |